Feb 16: 1 Strong Theme — Biosimilars
1 strong theme — 1 new. Top: Biosimilars +12.1%.
Average change by strong theme
Theme leaders · recent trend
| Theme | Leader | Change | Trend |
|---|---|---|---|
| Biosimilars | Celltrion | +15.00% |
Biosimilars was the standout theme on Feb 16, posting an average change of 12.13%. All 4 stocks in the group closed higher, and the theme appeared as new with a streak of 1.
Celltrion led the move, rising 15.0% to close at 46244 on volume of 9865361 shares. Celltrion Pharm followed closely with a gain of 14.95%.
Hanall Biopharma added 11.41% and ISU Abxis gained 7.17%, so every stock in the group finished higher.
Today’s Strong Themes at a Glance
| # | Theme | Status | Avg. change | Up/Total | Leader |
|---|---|---|---|---|---|
| 1 | Biosimilars | new | +12.1% | 4/4 | Celltrion |
Theme by Theme
1. Biosimilars (new)
- Episode: started 2015-02-16, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
Celltrion 068270 | +15.0% | 46,244 | ★ |
Celltrion Pharm 068760 | +14.9% | 11,581 | |
Hanall Biopharma 009420 | +11.4% | 4,930 | |
ISU Abxis 086890 | +7.2% | 7,995 |
Related news
- [특징주]이큐스앤자루, 바이오시밀러 뛰어넘는 신약 중국 계약 추진…↑ — 이투데이 (Korean)
- [특징주]시노펙스, 미 FDA 승인 바이오시밀러 의료 필터 기대감…↑ — 이투데이 (Korean)
Closing Thoughts
A same-day Korean news report covered a company working toward a China deal for a drug pitched as going beyond biosimilars. Another pointed to hopes tied to an FDA-approved biosimilar filter.
The theme has a streak of 1, so the coming sessions will show whether the move lasts beyond Feb 16. Another point to track is whether all 4 stocks keep moving together.